Your search returned 4 results.

Results
	1.	Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma. [electronic resource] by Kulus, M Hébert, J Garcia, E Fowler Taylor, A Fernandez Vidaurre, C Blogg, M Producer: 20100908 In: Current medical research and opinion vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. [electronic resource] by Busse, W Corren, J Lanier, B Q McAlary, M Fowler-Taylor, A Cioppa, G D van As, A Gupta, N Producer: 20010906 In: The Journal of allergy and clinical immunology vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma. [electronic resource] by Massanari, M Milgrom, H Pollard, S Maykut, R J Kianifard, Farid Fowler-Taylor, A Geba, G P Zeldin, R K Producer: 20100106 In: Clinical pediatrics vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. [electronic resource] by Casale, T B Condemi, J LaForce, C Nayak, A Rowe, M Watrous, M McAlary, M Fowler-Taylor, A Racine, A Gupta, N Fick, R Della Cioppa, G Producer: 20020114 In: JAMA vol. 286 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)